"50242-125-01" National Drug Code (NDC)

NDC Code	50242-125-01
Package Description	1 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE
Product NDC	50242-125
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Columvi
Non-Proprietary Name	Glofitamab
Dosage Form	SOLUTION, CONCENTRATE
Usage	INTRAVENOUS
Start Marketing Date	20230615
Marketing Category Name	BLA
Application Number	BLA761309
Manufacturer	Genentech, Inc.
Substance Name	GLOFITAMAB
Strength	2.5
Strength Unit	mg/2.5mL
Pharmacy Classes	Bispecific CD20-directed CD3 T Cell Engager [EPC], CD20-directed Antibody Interactions [MoA], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Cytochrome P450 Inhibitors [MoA], Increased Cytokine Activity [PE]